UNSPSC 51373330: Aspirin/pentazocine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373330 Aspirin/pentazocine is a Commodity code that covers pharmaceutical products including analgesics and opioid pain relievers, though recent state and local solicitations under this code show substantial divergence from the nominal scope. The recent opportunities reflect procurement of pharmaceutical products more broadly—including naloxone, generic multi-source pharmaceuticals, and over-the-counter medications—rather than aspirin or pentazocine specifically. State and local governments buying under this code include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances. The work involves supplying pharmaceutical products in bulk quantities to support public health initiatives, community health programs, and state employee and retiree health plans. Vendors must typically comply with federal and state pharmaceutical regulations, maintain appropriate insurance coverage, demonstrate manufacturing and supply-chain compliance (including cGMP and DSCSA certification), and submit detailed product information with National Drug Codes and pricing structures.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the county community health building; the procurement included E-Verify compliance and workers' compensation and liability insurance requirements with potential FEMA funding. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) to gather vendor capability information on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements, signaling early-stage market research before formal procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed across state and local government facilities in Minnesota and Oregon, with awarded vendors required to distribute through authorized wholesalers and comply with 3 percent administrative fees and performance penalties. Vendor responses indicate that this code attracts both direct institutional procurement and multistate cooperative contracting vehicles.